Alcorn Sara R, Sloan Lindsey, McNutt Todd R, Stinson Susan F, Asrari Fariba, Croog Victoria J, Floreza Bethlehem, Weaver Arcelia, Wright Jean L
Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Rep Pract Oncol Radiother. 2020 May-Jun;25(3):345-350. doi: 10.1016/j.rpor.2020.02.009. Epub 2020 Feb 21.
Adjacent tissues-in-beam (TIB) may receive substantial incidental doses within standard tangent fields during hypofractioned whole breast irradiation (HF-WBI). To characterize the impact of dose to TIB, we analyzed dosimetric parameters of TIB and associated acute toxicity.
Plans prescribed to 40.5 Gy/15 fractions from 4/2016-1/2018 were evaluated. Structures of interest were contoured: (1) TIB: all tissues encompassed by plan 30% isodose lines, (2) breast, (3) non-breast TIB (nTIB): TIB minus contoured breast. Volumes of TIB, breast, and nTIB receiving 100%-107% of prescription dose (V100-V107) were calculated. Twelve patient- and physician-reported acute toxicities were prospectively collected weekly. Correlations between volumetric and dosimetric parameters were assessed. Uni- and multivariable logistic regressions evaluated toxicity grade changes as a function of TIB, breast, and nTIB V100-V107 (in cm).
We evaluated 137 plans. Breast volume was positively correlated with nTIB and nTIB V100 (rho = 0.52, rho = 0.30, respectively, both p < 0.001). V107 > 2 cm were noted in 14% of breast and 21% of nTIB volumes. On multivariable analyses, increasing breast and nTIB V100 significantly raised odds of grade 2+ dermatitis and burning/twinging pain, respectively; increasing nTIB V105 elevated odds of hyperpigmentation and burning pain; and increasing nTIB V107 raised odds of burning pain. Threshold volumes for >6-fold odds of developing burning pain were TIB V105 > 100 cm and V107 > 5 cm.
For HF-WBI, doses to nTIB over the prescription predicted acute toxicities independent of breast doses. These data support inclusion of TIB as a region of interest in treatment planning and protocol design.
在大分割全乳照射(HF-WBI)期间,射野内相邻组织(TIB)在标准切线野中可能会接受大量的附带剂量。为了描述TIB剂量的影响,我们分析了TIB的剂量学参数及相关急性毒性。
评估2016年4月至2018年1月期间处方剂量为40.5Gy分15次照射的计划。勾勒出感兴趣的结构:(1)TIB:计划30%等剂量线所包含的所有组织;(2)乳腺;(3)非乳腺TIB(nTIB):TIB减去勾勒出的乳腺。计算接受处方剂量100%-107%(V100-V107)的TIB、乳腺和nTIB的体积。前瞻性地每周收集12项患者和医生报告的急性毒性反应。评估体积参数和剂量学参数之间的相关性。单变量和多变量逻辑回归评估毒性分级变化与TIB、乳腺和nTIB的V100-V107(单位:cm)的函数关系。
我们评估了137个计划。乳腺体积与nTIB和nTIB的V100呈正相关(相关系数分别为0.52和0.30,均p<0.001)。14%的乳腺体积和21%的nTIB体积中观察到V107>2cm。在多变量分析中,乳腺和nTIB的V100增加分别显著增加2级及以上皮炎和灼痛/刺痛的几率;nTIB的V105增加会增加色素沉着和灼痛的几率;nTIB的V107增加会增加灼痛的几率。发生灼痛几率增加6倍以上的阈值体积为TIB的V105>100cm和V107>5cm。
对于HF-WBI,超过处方剂量的nTIB剂量可预测独立于乳腺剂量的急性毒性。这些数据支持将TIB纳入治疗计划和方案设计中的感兴趣区域。